Search alternatives:
"haves" » "havens", "waves", "haven"

1
Published 2020
Canadian Agency for Drugs and Technologies in Health
... as well, including the eyes, lungs, heart, or skin. It is estimated that about 1% of Canadians have...

2
Published 2020
Canadian Agency for Drugs and Technologies in Health
... as well, including the eyes, lungs, heart, or skin. It is estimated that about 1% of Canadians have...

3
Published 2020
Canadian Agency for Drugs and Technologies in Health
... drugs (DMARDs) who have had inadequate response or intolerance to methotrexate. 2. Upadacitinib should...

4
Published 2020
Canadian Agency for Drugs and Technologies in Health
... drugs (DMARDs) who have had inadequate response or intolerance to methotrexate. 2. Upadacitinib should...

5
Published 2020
CADTH
...) be reimbursed for the treatment of iron deficiency anemia (IDA) in adult patients who have intolerance...

6
Published 2020
CADTH
...) be reimbursed for the treatment of iron deficiency anemia (IDA) in adult patients who have intolerance...

7
Published 2018
Canadian Agency for Drugs and Technologies in Health
... for the treatment of adult patients with active PsA who have responded inadequately to, or are intolerant to one...

8
Published 2018
Canadian Agency for Drugs and Technologies in Health
... for the treatment of adult patients with active PsA who have responded inadequately to, or are intolerant to one...

9
Published 2019
Canadian Agency for Drugs and Technologies in Health
... in combination with MTX for the treatment of adult patients with moderate to severe RA who have responded...

10
Published 2019
Canadian Agency for Drugs and Technologies in Health
... in combination with MTX for the treatment of adult patients with moderate to severe RA who have responded...

11
Published 2018
CADTH
... (HCV) infection, without cirrhosis or with compensated cirrhosis, who have: genotype 1, 2, 3, 4, 5...

12
Published 2019
Canadian Agency for Drugs and Technologies in Health
...) in patients who have been previously treated with a course of corticosteroids and did not have a clinically...

13
Published 2018
CADTH
... (HCV) infection, without cirrhosis or with compensated cirrhosis, who have: genotype 1, 2, 3, 4, 5...

14
Published 2019
Canadian Agency for Drugs and Technologies in Health
...) in patients who have been previously treated with a course of corticosteroids and did not have a clinically...

15
Published 2020
Canadian Agency for Drugs and Technologies in Health
... with moderately to severely active UC who have had an inadequate response with, lost response to, orwere...

16
Published 2020
Canadian Agency for Drugs and Technologies in Health
... have a fasting TG of 1.7 mmol/L or greater and lower than 5.6 mmol/L at baseline, measured within...

17
Published 2020
CADTH
... for the treatment of adult patients with active ankylosing spondylitis who have responded inadequately...

18
Published 2016
Canadian Agency for Drugs and Technologies in Health
... have had an inadequate response to conventional therapy including corticosteroids, azathioprine...

19
Published 2020
CADTH
... for the treatment of adult patients with active ankylosing spondylitis who have responded inadequately...

20
Published 2020
Canadian Agency for Drugs and Technologies in Health
...Erenumab has a Health Canada indication for the prevention of migraines in patients who have...